Literature DB >> 22959975

Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.

Mohammad Murtaza Mehdi1, Syed Ibrahim Rizvi.   

Abstract

BACKGROUND AND AIMS: The role of free radicals has long been proposed as a cause for the aging process. Oxidative stress is considered a major factor for altering many physiological processes and enzymatic activities during aging and is also known to play a major role in the development of several age-dependent diseases. Paraoxonase 1 (PON1) is an anti-atherosclerotic enzyme that mainly prevents accumulation of lipoperoxides and inhibits the lipid oxidation in low-density lipoproteins (LDL). This study was undertaken to investigate the antioxidant behavior of PON1 by measuring its arylesterase activity. The susceptibility of LDL for oxidation and the radical scavenging activity of plasma were also measured during aging in humans.
METHODS: Arylesterase activity of PON1 was measured in plasma of human subjects between 20 and 81 years of age of both genders. The susceptibility of LDL for oxidation and radical scavenging activity were measured in plasma.
RESULTS: Decrease in plasma arylesterase activity of PON1, increase in susceptibility of LDL for oxidation and decrease in plasma radical scavenging activity were observed as a function of human age.
CONCLUSIONS: The study provides evidence of a relationship between PON1 activity, LDL oxidation and free radical scavenging activity of plasma. The present results emphasize the dependency of PON1 activity to prevailing oxidative stress during human aging. Our findings assume significance in view of the possible categorization of PON1 as a longevity gene.
Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959975     DOI: 10.1016/j.arcmed.2012.08.012

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  8 in total

Review 1.  Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.

Authors:  Gan-Zhong Wei; Mei-Yan Zhu; Fang Wang; Yue-Guang Zhao; Shan-Shan Li; Tong-Yang Liu; Ying Luo; Wen-Ru Tang
Journal:  Z Gerontol Geriatr       Date:  2015-05-12       Impact factor: 1.281

2.  Protective effect of hesperidin in Poloxamer-407 induced hyperlipidemic experimental rats.

Authors:  Raushan Kumar; Farhan Akhtar; Syed Ibrahim Rizvi
Journal:  Biol Futur       Date:  2021-01-03

3.  Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.

Authors:  Sangmee Sharon Bae; Ani Shahbazian; Jennifer Wang; Ilana Golub; Buzand Oganesian; Tyler Dowd; Beata Vayngortin; Ryan Wang; David Elashoff; Srinivasa T Reddy; Christina Charles-Schoeman
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046

Review 4.  Interdependence of Anti-Inflammatory and Antioxidant Properties of Squalene-Implication for Cardiovascular Health.

Authors:  Nurul 'Izzah Ibrahim; Isa Naina Mohamed
Journal:  Life (Basel)       Date:  2021-01-29

5.  Age-dependent paraoxonase 1 (PON1) activity and LDL oxidation in Wistar rats during their entire lifespan.

Authors:  Dileep Kumar; Syed Ibrahim Rizvi
Journal:  ScientificWorldJournal       Date:  2014-05-22

6.  Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.

Authors:  Subramaniam Rajesh Bharathidevi; Kannadasan Anand Babu; Nishit Jain; Sivashanmugam Muthukumaran; Vetrivel Umashankar; J Biswas; Narayanasamy Angayarkanni
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

7.  Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients.

Authors:  George Awuku Asare; Sabina Ekua Andam; Henry Asare-Anane; Seth Ammanquah; Yvonne Anang-Quartey; Daniel K Afriyie; Iddis Musah
Journal:  Prostate Int       Date:  2017-04-20

Review 8.  Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview.

Authors:  Débora Levy; Cadiele Oliana Reichert; Sérgio Paulo Bydlowski
Journal:  Antioxidants (Basel)       Date:  2019-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.